FFA
ALDX icon

Farther Finance Advisors’s Aldeyra Therapeutics ALDX Stock Holding History

Farther Finance Advisors’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.57K Buy
4,497
+47
+1% +$81 ﹤0.01% 4448
2026
Q1 		$7.48K Buy
4,450
+495
+13% +$2.17K ﹤0.01% 4293
2025
Q4 		$20.5K Buy
3,955
+49
+1% +$252 ﹤0.01% 3424
2025
Q3 		$20.4K Hold
3,906
– – ﹤0.01% 3029
2025
Q2 		$15K Sell
3,906
-3,000
-43% -$7.76K ﹤0.01% 2853
2025
Q1 		$37.8K Hold
6,906
– – ﹤0.01% 2044
2024
Q4 		$34.5K Hold
6,906
– – ﹤0.01% 1837
2024
Q3 		$37.2K Hold
6,906
– – ﹤0.01% 1798
2024
Q2 		$22.4K Hold
6,906
– – ﹤0.01% 1743
2024
Q1 		$22.6K Buy
6,906
+3,901
+130% +$12.8K ﹤0.01% 1451
2023
Q4 		$10.5K Buy
+3,005
New +$9.27K ﹤0.01% 1582

Other funds holding ALDX

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
WC
Woodstock Corp Boston, Massachusetts $1.2B AUM 26.37% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Farther Finance Advisors's ALDX Position: Q2 2026 in Review

Farther Finance Advisors increased its Aldeyra Therapeutics (ALDX) stake by 1.1% in Q2 2026, buying an estimated $81 and bringing the position to 4,497 shares worth $9.57K. The position accounts for ﹤0.01% of the portfolio, ranked #4448.

Farther Finance Advisors first reported a position in ALDX in Q4 2023 and has held it in 11 quarters since. The position peaked at $37.8K in Q1 2025. 10 funds tracked by Wall St. Rank hold ALDX as of Q2 2026.

  • Farther Finance Advisors held 4,497 shares of Aldeyra Therapeutics worth $9.57K as of Q2 2026.
  • Farther Finance Advisors bought 47 Aldeyra Therapeutics shares in Q2 2026, an estimated $81.
  • Aldeyra Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4448 holding.
  • Farther Finance Advisors first reported a position in Aldeyra Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • Farther Finance Advisors's Aldeyra Therapeutics position peaked at $37.8K in Q1 2025.
  • 10 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.